CDXS News and Press, Codexis Inc. From 08/03/23

2023-08-03 16:31:33 ET Codexis press release ( NASDAQ: CDXS ): Q2 GAAP EPS of -$0.17 beats by $0.04 . Revenue of $21.32M (-44.5% Y/Y) in-line. 2023 Financial Guidance Codexis reiterated its 2023 financial guidance issued on July 20, 2023, as follows: Pr...

Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization Anticipate Demonstrating Gram-Scale Synthesis of ECO Synthesis™ Technology for RNAi Therapeutics Production by End of Year Projected Cash Runway to Mid-2026 Funds Important ECO Synthesis!...

REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the launch of a new mini documentary as part of an ongoing campaign in support of World Health Day. The film showcases the Company’s recently unveiled...

2023-07-20 18:32:06 ET Codexis ( NASDAQ: CDXS ) said that as part of its strategic focus, it will streamline operations, including laying off ~25% of its staff. The enzyme engineering company said it will prioritize the advancement and marketing of its Enzyme-Catalyzed Oligonu...

Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis™ Platform for RNAi Therapeutics Production Codexis Expects its Pharmaceutical Manufacturing Business to Return to Growth in 2024 Company Reiterates 2023 Product Revenue Guida...

2023-07-06 17:26:36 ET Gainers: Century Therapeutics ( NASDAQ: IPSC ) +8% . Codexis ( CDXS ) +5% . Alignment Healthcare ( ALHC ) +4% . Wag! Group  ( PET ) +4% . Cadiz ( CDZI ) +3% . Losers: Renalytix  ( RN...

2023-06-27 17:26:51 ET Gainers: Geospace Technologies ( GEOS ) +7% . AeroVironment ( AVAV ) +6% . Codexis ( CDXS ) +5% . Recursion Pharmaceuticals ( RXRX ) +3% . CECO Environmental  ( CECO ) +3% . Losers: AST SpaceMo...

REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Healthcare Conference, being held June 7-9, 2023, in New York, New York. Management will participate in a fireside...

REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the unveiling of its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis™ technology, a proprietary new synthesis platform being developed for manufacturi...

2023-05-04 16:25:12 ET Codexis press release ( NASDAQ: CDXS ): Q1 Non-GAAP EPS of -$0.39. Revenue of $12.98M (-63.3% Y/Y) misses by $1.11M . CDXS reiterated its 2023 total revenue guidance range of $63 million to $68 million, excluding enzyme sales related to Paxlo...